KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Payables (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Payables for 11 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 13.48% year-over-year to $28.1 million, compared with a TTM value of $28.1 million through Dec 2025, down 13.48%, and an annual FY2025 reading of $28.1 million, down 13.48% over the prior year.
  • Payables was $28.1 million for Q4 2025 at Medpace Holdings, up from $26.5 million in the prior quarter.
  • Across five years, Payables topped out at $249.7 million in Q2 2022 and bottomed at $21.3 million in Q1 2021.
  • Average Payables over 5 years is $63.7 million, with a median of $31.9 million recorded in 2023.
  • The sharpest move saw Payables surged 970.48% in 2022, then crashed 83.96% in 2024.
  • Year by year, Payables stood at $25.7 million in 2021, then skyrocketed by 223.5% to $83.1 million in 2022, then plummeted by 61.64% to $31.9 million in 2023, then grew by 2.07% to $32.5 million in 2024, then dropped by 13.48% to $28.1 million in 2025.
  • Business Quant data shows Payables for MEDP at $28.1 million in Q4 2025, $26.5 million in Q3 2025, and $43.3 million in Q2 2025.